Advanced search
Publication Cover
Drug Delivery Volume 28, 2021 - Issue 1
Submit an article Journal homepage
1,348
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Determining the effect of ocular chemical injuries on topical drug delivery

Ghazala Beguma Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK;b NIHR Surgical Reconstruction and Microbiology Research Centre, University of Birmingham, Birmingham, UKView further author information
,
Thomas Leighc School of Chemistry, University of Birmingham, Birmingham, UKView further author information
,
David Stanleya Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UKView further author information
,
Ann Logand Axolotl Consulting Ltd, Droitwich, UK;e Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UKView further author information
&
Richard James Blancha Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK;b NIHR Surgical Reconstruction and Microbiology Research Centre, University of Birmingham, Birmingham, UK;f Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, UK;g Department of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UKCorrespondence[email protected]
View further author information
Pages 2044-2050 | Received 06 Jul 2021, Accepted 06 Sep 2021, Published online: 01 Oct 2021

References

  • Baradaran-Rafii A, Eslani M, Haq Z, et al. (2017). Current and upcoming therapies for ocular surface chemical injuries. Ocul Surf 15:48–64.
  • Begum G, Leigh T, Courtie E, et al. (2020). Rapid assessment of ocular drug delivery in a novel ex vivo corneal model. Sci Rep 10:11754.
  • Blanch R, Raux S, Woodcock M, et al. (2018). Ocular trauma. In: Denniston AK, Murray PI, eds. Oxford handbook of ophthalmology. 4th ed. Oxford (UK): Oxford University Press, 114–23.
  • Brodovsky SC, McCarty CA, Snibson G, et al. (2000). Management of alkali burns: an 11-year retrospective review. Ophthalmology 107:1829–35.
  • Chen Q, Zielinski D, Chen J, et al. (2008). A validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents. J Pharm Biomed Anal 48:732–8.
  • Davis AR, Ali QK, Aclimandos WA, et al. (1997). Topical steroid use in the treatment of ocular alkali burns. Br J Ophthalmol 81:732–4.
  • Fish R, Davidson RS. (2010). Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol 21:317–21.
  • Fukuda M, Sasaki H. (2016). In vivo measurement of human corneal impedance value. Cornea 35:1305–7.
  • Gérard M, Louis V, Merle H, et al. (1999). Experimental study about intra-ocular penetration of ammonia. J Fr Ophtalmol 22:1047–53.
  • Ghosh S, Salvador-Culla B, Kotagiri A, et al. (2019). Acute chemical eye injury and limbal stem cell deficiency—a prospective study in the United Kingdom. Cornea 38:8–12.
  • Guimera A, Gabriel G, Plata-Cordero M, et al. (2012). A non-invasive method for an in vivo assessment of corneal epithelium permeability through tetrapolar impedance measurements. Biosens Bioelectron 31:55–61.
  • Heng LZ, Hamilton RD. (2018). Ocular emergencies. Medicine 46:754–9.
  • Kaler G, Truong DM, Khandelwal A, et al. (2007). Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem 282:23841–53.
  • Kaluzhny Y, Kinuthia MW, Truong T, et al. (2018). New human organotypic corneal tissue model for ophthalmic drug delivery studies. Invest Ophthalmol Vis Sci 59:2880–98.
  • Kuckelkorn R, Schrage N, Keller G, Redbrake C. (2002). Emergency treatment of chemical and thermal eye burns. Acta Ophthalmol Scand 80:4–10.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25.
  • Lombardo F, Shalaeva MY, Tupper KA, et al. (2000). ElogP.OCT: a tool for lipophilicity determination in drug discovery. J Med Chem 43:2922–8.
  • Nassr MA, Morris CL, Netland PA, Karcioglu ZA. (2009). Intraocular pressure change in orbital disease. Surv Ophthalmol 54:519–44.
  • Paschalis EI, Zhou C, Lei F, et al. (2017). Mechanisms of retinal damage after ocular alkali burns. Am J Pathol 187:1327–42.
  • Pfister RR. (1983). Chemical injuries of the eye. Ophthalmology 90:1246–53.
  • Ramponi DR. (2017). Chemical burns of the eye. Adv Emerg Nurs J 39:193–8.
  • Sharma N, Kaur M, Agarwal T, et al. (2018). Treatment of acute ocular chemical burns. Surv Ophthalmol 63:214–35.
  • Singh P, Tyagi M, Kumar Y, et al. (2013). Ocular chemical injuries and their management. Oman J Ophthalmol 6:83–6.
  • Uematsu M, Mohamed YH, Onizuka N, et al. (2016). Less invasive corneal transepithelial electrical resistance measurement method. Ocul Surf 14:37–42.
  • Wagoner MD. (1997). Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 41:275–313.
  • White ML, Chodosh J, Jang J, Dohlman C. (2015). Incidence of Stevens-Johnson syndrome and chemical burns to the eye. Cornea 34:1527–33.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.